July 30 (Reuters) - Avenira Ltd (AEV) :
- STRATEGIC INVESTMENT FROM SICHUAN HEBANG BIOTECHNOLOGY
- INVESTMENT COMPRISES A$4.5 MILLION 2-TRANCHE PLACEMENT AT ISSUE PRICE OF A$0.006 PER NEW SHARE, AMONG OTHERS
- AS PART OF INVESTMENT, HEBANG HAS RIGHT TO APPOINT EXECUTIVE CHAIRMAN TO BOARD, AND A CEO AND CFO TO MANAGEMENT TEAM
- FOLLOWING COMPLETION OF TRANCHE 1, CO WILL APPOINT MO YANG AS EXECUTIVE CHAIRMAN AND CEO
(([email protected];))
News: AEV Avenira Says Strategic Investment From Sichuan Hebang Biotechnology
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
0.8¢ |
Change
0.001(14.3%) |
Mkt cap ! $34.06M | |||
| Open | High | Low | Value | Volume |
| 0.8¢ | 0.8¢ | 0.8¢ | $18.27K | 2.315M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 242642 | 0.7¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.8¢ | 4772857 | 9 |
View Market Depth
| Last trade - 14.43pm 12/09/2025 (20 minute delay) ? |
| AEV (ASX) Chart |